Equillium Inc (NASDAQ: EQ) on Tuesday, soared 22.59% from the previous trading day, before settling in for the closing price of $0.29. Within the past 52 weeks, EQ’s price has moved between $0.28 and $1.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 31.13% over the past five years. The company achieved an average annual earnings per share of -269.57%. With a float of $17.58 million, this company’s outstanding shares have now reached $35.72 million.
Let’s look at the performance matrix of the company that is accounted for 35 employees. In terms of profitability, gross margin is 99.77%, operating margin of -47.18%, and the pretax margin is -44.81%.
Equillium Inc (EQ) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Equillium Inc is 50.77%, while institutional ownership is 5.11%. The most recent insider transaction that took place on Jun 12 ’25, was worth 3,860. Before that another transaction happened on Jan 23 ’25, when Company’s Chief Financial Officer sold 10,000 for $0.65, making the entire transaction worth $6,500. This insider now owns 37,720 shares in total.
Equillium Inc (EQ) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -269.57% per share during the next fiscal year.
Equillium Inc (NASDAQ: EQ) Trading Performance Indicators
Equillium Inc (EQ) is currently performing well based on its current performance indicators. A quick ratio of 2.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -1.09 in one year’s time.
Technical Analysis of Equillium Inc (EQ)
Equillium Inc (NASDAQ: EQ) saw its 5-day average volume 0.35 million, a negative change from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 23.75%.
During the past 100 days, Equillium Inc’s (EQ) raw stochastic average was set at 11.25%, which indicates a significant decrease from 54.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 126.43% in the past 14 days, which was lower than the 126.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3956, while its 200-day Moving Average is $0.6831. Nevertheless, the first resistance level for the watch stands at $0.3882 in the near term. At $0.4209, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4800. If the price goes on to break the first support level at $0.2964, it is likely to go to the next support level at $0.2373. The third support level lies at $0.2046 if the price breaches the second support level.
Equillium Inc (NASDAQ: EQ) Key Stats
Market capitalization of the company is 12.70 million based on 35,719K outstanding shares. Right now, sales total 41,100 K and income totals -8,070 K. The company made 4,390 K in profit during its latest quarter, and -5,790 K in sales during its previous quarter.
